Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Synthetic Biologics, Inc. SYN

Set alert

Price alert · SYN

All alert types
1.02 0.00 0.00%

At close

0.9724 Day range 1.02

52-week range unavailable

Open
1.02
Prev close
1.02
Mkt cap
16.16M
Vol
57.79K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.9724
High
1.02
Forward P/E
-0.65
Beta
1.39
Short ratio
4.75
Inst. own
8.08%
Dividend
0.00
Ex-div date
Earnings
Nov 2, 2022
50-d avg
1.27
200-d avg
2.08
1y target
5.50

6M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • May 16, 2022Earnings: —; estimate 0; surprise —%
  • Jul 25, 2022Split: 1 for 10
  • Aug 11, 2022Earnings: —; estimate 0; surprise —%
Signals (15)
NameDateAgo
MACD: Buy SignalOct 5, 20224 years ago
RSI: OversoldSep 20, 20224 years ago
MACD: Sell SignalSep 16, 20224 years ago
MACD: Buy SignalAug 5, 20224 years ago
RSI: OversoldJul 26, 20224 years ago
SMA: BearishJul 15, 20224 years ago
MACD: Sell SignalJul 15, 20224 years ago
SMA: BullishJul 1, 20224 years ago
MACD: Buy SignalJun 27, 20224 years ago
MACD: Sell SignalJun 14, 20224 years ago
MACD: Buy SignalMay 25, 20224 years ago
MACD: Sell SignalMay 24, 20224 years ago
MACD: Buy SignalMay 18, 20224 years ago
MACD: Sell SignalMay 11, 20224 years ago
MACD: Buy SignalMay 4, 20224 years ago

Financial health

Altman Z-Score

-15.06 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.5×
FY 2015: -4.2×FY 2016: -2.6×FY 2017: -4.2×FY 2018: -0.3×FY 2019: -0.5×FY 2020: -0.7×FY 2021: -2.3×FY 2022: -0.8×FY 2024: -0.1×FY 2025: -0.5×
FY 2015 5y median -0.7× FY 2025
P/S 0.0×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025
P/B 0.8×
FY 2015: 11.5×FY 2016: 18.7×FY 2017: -42.2×FY 2018: 0.1×FY 2019: 0.6×FY 2020: 0.9×FY 2021: 0.5×FY 2022: 0.3×FY 2024: 0.1×FY 2025: 0.8×
FY 2015 5y median 0.5× FY 2025
P/FCF -0.7×
FY 2015: -4.7×FY 2016: -2.5×FY 2017: -3.1×FY 2018: -0.2×FY 2019: -0.6×FY 2020: -0.6×FY 2021: -2.6×FY 2022: -0.8×FY 2024: -0.1×FY 2025: -0.7×
FY 2015 5y median -0.7× FY 2025
EV/EBITDA -0.0×
FY 2015: -3.8×FY 2016: -2.0×FY 2017: -3.1×FY 2018: 1.9×FY 2019: 0.4×FY 2020: -0.2×FY 2021: 2.3×FY 2022: 1.1×FY 2024: -63.9×FY 2025: -0.0×
FY 2015 5y median -0.0× FY 2025
EV/Sales 0.0×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025
FCF Yield -134.9%
FY 2015: -21.3%FY 2016: -39.6%FY 2017: -32.3%FY 2018: -495.3%FY 2019: -166.5%FY 2020: -167.2%FY 2021: -38.9%FY 2022: -122.8%FY 2024: -1231.8%FY 2025: -134.9%
FY 2015 5y median -134.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
ROE -164.1%
FY 2015: -272.5%FY 2016: -708.8%FY 2017: 1014.3%FY 2018: -45.5%FY 2019: -106.5%FY 2020: -125.1%FY 2021: -21.8%FY 2022: -38.0%FY 2024: -134.5%FY 2025: -164.1%
FY 2015 5y median -125.1% FY 2025
ROIC -83.4%
FY 2015: -245.6%FY 2016: -1432.0%FY 2017: -290.2%FY 2018: -65.7%FY 2019: -128.3%FY 2020: -176.5%FY 2021: -21.3%FY 2022: -30.9%FY 2024: -92.9%FY 2025: -83.4%
FY 2015 5y median -83.4% FY 2025
ROA -66.0%
FY 2015: -141.8%FY 2016: -121.1%FY 2017: -80.5%FY 2018: -44.3%FY 2019: -88.8%FY 2020: -119.4%FY 2021: -20.3%FY 2022: -27.4%FY 2024: -72.6%FY 2025: -66.0%
FY 2015 5y median -66.0% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 FY 2025
Operating Income 8.7%
FY 2015: -99.9%FY 2016: 4.2%FY 2017: 33.1%FY 2018: 33.1%FY 2019: 10.9%FY 2020: 35.1%FY 2021: -40.4%FY 2022: -51.3%FY 2024: 0.0%FY 2025: 8.7%
FY 2015 FY 2025
EPS (diluted) 89.1%
FY 2015: -69.7%FY 2016: 46.7%FY 2017: 57.8%FY 2018: 49.8%FY 2019: 56.6%FY 2020: 43.3%FY 2021: 77.8%FY 2022: -9.4%FY 2024: 0.0%FY 2025: 89.1%
FY 2015 FY 2025
Free Cash Flow 1.4%
FY 2015: -144.3%FY 2016: 27.7%FY 2017: 28.3%FY 2018: 15.3%FY 2019: 19.7%FY 2020: 12.2%FY 2021: -6.0%FY 2022: -48.8%FY 2024: 0.0%FY 2025: 1.4%
FY 2015 FY 2025

Financial Health

Current Ratio 1.7×
FY 2015: 1.9×FY 2016: 1.1×FY 2017: 1.8×FY 2018: 8.7×FY 2019: 3.1×FY 2020: 2.7×FY 2021: 19.4×FY 2022: 6.4×FY 2024: 2.1×FY 2025: 1.7×
FY 2015 5y median 2.7× FY 2025
Quick Ratio 1.7×
FY 2015: 1.9×FY 2016: 1.1×FY 2017: 1.8×FY 2018: 8.7×FY 2019: 3.1×FY 2020: 2.7×FY 2021: 19.4×FY 2022: 6.4×FY 2024: 2.1×FY 2025: 1.7×
FY 2015 5y median 2.7× FY 2025
Debt / Equity 0.1×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2024: 0.1×FY 2025: 0.1×
FY 2015 5y median 0.1× FY 2025
Net Debt / EBITDA 0.5×
FY 2015: 0.5×FY 2016: 0.7×FY 2017: 1.1×FY 2018: 2.2×FY 2019: 1.0×FY 2020: 0.6×FY 2021: 4.6×FY 2022: 1.9×FY 2024: -74.0×FY 2025: 0.5×
FY 2015 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -2377×FY 2022: 45.8×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 334.7%FY 2019: 6.3%FY 2020: 19.0%FY 2021: 4.5%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: -87.4%FY 2019: -3.4%FY 2020: -13.7%FY 2021: -10.5%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31